KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Debt (2016 - 2026)

Idexx Laboratories has reported Total Debt over the past 17 years, most recently at $449.8 million for Q4 2025.

  • For Q4 2025, Total Debt fell 27.16% year-over-year to $449.8 million; the TTM value through Dec 2025 reached $449.8 million, down 27.16%, while the annual FY2025 figure was $449.8 million, 27.16% down from the prior year.
  • Total Debt for Q4 2025 was $449.8 million at Idexx Laboratories, down from $524.8 million in the prior quarter.
  • Over five years, Total Debt peaked at $1.4 billion in Q3 2022 and troughed at $449.8 million in Q4 2025.
  • A 5-year average of $812.7 million and a median of $811.0 million in 2021 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: skyrocketed 63.4% in 2022 and later plummeted 37.67% in 2023.
  • Year by year, Total Debt stood at $848.7 million in 2021, then rose by 11.27% to $944.4 million in 2022, then dropped by 26.1% to $697.9 million in 2023, then decreased by 11.51% to $617.6 million in 2024, then dropped by 27.16% to $449.8 million in 2025.
  • Business Quant data shows Total Debt for IDXX at $449.8 million in Q4 2025, $524.8 million in Q3 2025, and $1.0 billion in Q2 2025.